SCHEMBL4866909

SCHEMBL4866909

O=C(O)c1cc2c(s1)c(-c1ccccc1)c(-c1ccc3nc(-c4ccc(F)c(F)c4)ccc3c1)n2Cc1ccncc1

nearest known ligand 0.35

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALOX5AP P20292 5/20 0.35
GRIN1 Q05586 1/20 0.35
GRIN2B Q13224 1/20 0.35
USP2 O75604 1/20 0.34
CYP1A2 P05177 1/20 0.34
CYP3A4 P08684 1/20 0.34
CYP2C9 P11712 1/20 0.34
MAPK1 P28482 1/20 0.34
CYP2C19 P33261 1/20 0.34
KMO O15229 1/20 0.34
TOP1 P11387 1/20 0.34
S1PR3 Q99500 1/20 0.34
MDM2 Q00987 3/20 0.33
MDM4 O15151 2/20 0.33
RIPK3 Q9Y572 1/20 0.32
PPARG P37231 1/20 0.32
PTGES O14684 1/20 0.32
PDE10A Q9Y233 1/20 0.31
CYP11B2 P19099 1/20 0.31
MEN1 O00255 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4873278 0.92 GRIN1 (0.37) ALOX5APGRIN1GRIN2BUSP2CYP1A2
SCHEMBL4879018 0.92 MAPK14 (0.37) ALOX5APMDM2MDM4RIPK3CYP11B2
SCHEMBL4872023 0.91 CYP17A1 (0.36) GRIN1GRIN2BRIPK3PPARG
SCHEMBL4875185 0.87 PPARG (0.40) ALOX5APCYP3A4PPARG
SCHEMBL4868096 0.86 KDM4E (0.39) PPARGPTGESMEN1KMT2A
SCHEMBL4867600 0.86 DHODH (0.38) KMOPPARGPTGESPDE10AMEN1
SCHEMBL4877209 0.85 KDM4E (0.37) ALOX5APPPARGPDE10AMEN1KMT2A
SCHEMBL4866901 0.85 GRIN1 (0.33) ALOX5APGRIN1GRIN2BKMOMDM2
SCHEMBL4872488 0.84 KCNH2 (0.35) PPARGMEN1KMT2A
SCHEMBL4878284 0.84 MAOA (0.40) PPARGPDE10AKMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20080051384-A1 ANTIVIRAL AGENTS GENELABS TECHNOLOGIES, INC. 2008-02-28 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080051384-A1 ANTIVIRAL AGENTS EIF2AK2, MAVS, ZC3HAV1 ALOX5AP 3943/4885GRIN1 2653/4885GRIN2B 3420/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.